{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:33:18Z","timestamp":1793363598790,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T00:00:00Z","timestamp":1522022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11926-018-0732-6","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T09:31:40Z","timestamp":1522056700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":263,"title":["Immune-Mediated Necrotizing Myopathy"],"prefix":"10.1007","volume":"20","author":[{"given":"Iago","family":"Pinal-Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Casal-Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,26]]},"reference":[{"issue":"4","key":"732_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMc1506827","volume":"373","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015;373(4):393\u20134.","journal-title":"N Engl J Med"},{"issue":"5","key":"732_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14(5):337\u201345.","journal-title":"Neuromuscul Disord"},{"key":"732_CR3","unstructured":"\u2022\u2022 Allenbach Y, Mammen AL, Stenzel W, Benveniste O, Immune-mediated necrotizing myopathies working G. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016. Neuromuscul Disord 2017. Most recent classification criteria in IMNM. It includes consensus treatment recommendations for the different IMNM subsets."},{"issue":"5","key":"732_CR4","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/art.40063","volume":"69","author":"JL Senecal","year":"2017","unstructured":"Senecal JL, Raynauld JP, Troyanov Y. Editorial: a new classification of adult autoimmune myositis. Arthritis Rheumatol. 2017;69(5):878\u201384.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"732_CR5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/0006-291X(82)91923-4","volume":"109","author":"Y Nakao","year":"1982","unstructured":"Nakao Y, Mukai R, Kabashima T, Ohshima Y, Hamaguchi H, Kashiwagi H, et al. A novel antibody which precipitates 7.5S RNA is isolated from a patient with autoimmune disease. Biochem Biophys Res Commun. 1982;109(4):1332\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"732_CR6","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.4049\/jimmunol.138.10.3219","volume":"138","author":"N Okada","year":"1987","unstructured":"Okada N, Mimori T, Mukai R, Kashiwagi H, Hardin JA. Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle. J Immunol. 1987;138(10):3219\u201323.","journal-title":"J Immunol"},{"issue":"24","key":"732_CR7","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","volume":"83","author":"WH Reeves","year":"1986","unstructured":"Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signal-recognition particle. Proc Natl Acad Sci U S A. 1986;83(24):9507\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"732_CR8","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/art.27572","volume":"62","author":"L Christopher-Stine","year":"2010","unstructured":"Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 2010;62(9):2757\u201366.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"732_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011;63(3):713\u201321.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"732_CR10","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3899\/jrheum.141443","volume":"42","author":"I Pinal-Fernandez","year":"2015","unstructured":"Pinal-Fernandez I, Casciola-Rosen LA, Christopher-Stine L, Corse AM, Mammen AL. The prevalence of individual histopathologic features varies according to autoantibody status in muscle biopsies from patients with dermatomyositis. J Rheumatol. 2015;42(8):1448\u201354.","journal-title":"J Rheumatol"},{"issue":"10","key":"732_CR11","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/acr.22620","volume":"67","author":"JJ Paik","year":"2015","unstructured":"Paik JJ, Wigley FM, Lloyd TE, Corse AM, Casciola-Rosen L, Shah AA, et al. Spectrum of muscle histopathologic findings in forty-two scleroderma patients with weakness. Arthritis Care Res (Hoboken). 2015;67(10):1416\u201325.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"732_CR12","first-page":"19","volume":"33","author":"I Schneider","year":"2014","unstructured":"Schneider I, Stoltenburg G, Deschauer M, Winterholler M, Hanisch F. Limb girdle muscular dystrophy type 2L presenting as necrotizing myopathy. Acta Myol. 2014;33(1):19\u201321.","journal-title":"Acta Myol"},{"key":"732_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","volume":"10","author":"S Suzuki","year":"2015","unstructured":"\u2022\u2022 Suzuki S, Nishikawa A, Kuwana M, et al. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients. Orphanet J Rare Dis. 2015;10:61. Large study on the clinical features of anti-SRP patients.","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"732_CR14","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/annrheumdis-2013-205127","volume":"74","author":"C Dobloug","year":"2015","unstructured":"Dobloug C, Garen T, Bitter H, Stj\u00e4rne J, Stenseth G, Gr\u00f8vle L, et al. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann Rheum Dis. 2015;74(8):1551\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"732_CR15","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/rheumatology\/kew503","volume":"56","author":"J Svensson","year":"2017","unstructured":"Svensson J, Arkema EV, Lundberg IE, Holmqvist M. Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study. Rheumatology (Oxford). 2017;56(5):802\u201310.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"732_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/acr.22920","volume":"69","author":"I Pinal-Fernandez","year":"2017","unstructured":"\u2022\u2022 Pinal-Fernandez I, Parks C, Werner JL, et al. Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle. Arthritis care res (Hoboken). 2017;69(2):263\u201370. Longitudinal cohort study of anti-SRP patients.","journal-title":"Arthritis care res (Hoboken)"},{"issue":"7","key":"732_CR17","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.23113","volume":"69","author":"T Kishi","year":"2017","unstructured":"\u2022\u2022 Kishi T, Rider LG, Pak K, et al. Association of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies with DRB1*07:01 and severe myositis in juvenile myositis patients. Arthritis Care Res (Hoboken). 2017;69(7):1088\u201394. Report of juvenile anti-HMGCR cases from the USA.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"732_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3899\/jrheum.160871","volume":"44","author":"SL Tansley","year":"2017","unstructured":"\u2022\u2022 Tansley SL, Betteridge ZE, Simou S, et al. Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients. J Rheumatol. 2017;44(4):488\u201392. Report of juvenile anti-HMGCR cases from the UK.","journal-title":"J Rheumatol"},{"issue":"1","key":"732_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12969-017-0205-x","volume":"15","author":"EL Binns","year":"2017","unstructured":"\u2022 Binns EL, Moraitis E, Maillard S, et al. Effective induction therapy for anti-SRP associated myositis in childhood: a small case series and review of the literature. Pediatr Rheumatol Online J. 2017;15(1):77. Report of juvenile anti-SRP patients.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"732_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pediatrneurol.2011.04.009","volume":"45","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Ohta M, Shimizu Y, Hayashi YK, Nishino I. Anti-signal recognition particle myopathy in the first decade of life. Pediatr Neurol. 2011;45(2):114\u20136.","journal-title":"Pediatr Neurol"},{"issue":"5","key":"732_CR21","first-page":"787","volume":"56","author":"E Tiniakou","year":"2017","unstructured":"\u2022\u2022 Tiniakou E, Pinal-Fernandez I, Lloyd TE, et al. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford). 2017;56(5):787\u201394. Comprehensive longitudinal cohort study of patients with anti-HMGCR myositis.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"732_CR22","doi-asserted-by":"publisher","first-page":"e0141616","DOI":"10.1371\/journal.pone.0141616","volume":"10","author":"Y Ge","year":"2015","unstructured":"Ge Y, Lu X, Peng Q, Shu X, Wang G. Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies in Chinese patients with idiopathic inflammatory myopathies. PLoS One. 2015;10(10):e0141616.","journal-title":"PLoS One"},{"issue":"3","key":"732_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MD.0000000000000028","volume":"93","author":"Y Allenbach","year":"2014","unstructured":"Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB, et al. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore). 2014;93(3):150\u20137.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"732_CR24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","volume":"56","author":"I Pinal-Fernandez","year":"2017","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA, Albayda J, Paik JJ, Johnson C, et al. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies. Rheumatology (Oxford). 2017;56(6):999\u20131007.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"732_CR25","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/art.1780330908","volume":"33","author":"IN Targoff","year":"1990","unstructured":"Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum. 1990;33(9):1361\u201370.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"732_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/art.11484","volume":"50","author":"AH Kao","year":"2004","unstructured":"Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum. 2004;50(1):209\u201315.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"732_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/PL00007850","volume":"249","author":"GJ Hengstman","year":"2002","unstructured":"Hengstman GJ, Brouwer R, Egberts WT, et al. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol. 2002;249(1):69\u201375.","journal-title":"J Neurol"},{"issue":"6","key":"732_CR28","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/mus.25567","volume":"56","author":"P Mohassel","year":"2017","unstructured":"Mohassel P, Foley AR, Donkervoort S, Fequiere PR, Pak K, B\u00f6nnemann CG, et al. Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase necrotizing myopathy masquerading as a muscular dystrophy in a child. Muscle Nerve. 2017;56(6):1177\u201381.","journal-title":"Muscle Nerve"},{"issue":"6","key":"732_CR29","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/mus.25575","volume":"56","author":"Y Zhao","year":"2017","unstructured":"\u2022 Zhao Y, Liu X, Zhang W, Yuan Y. Childhood autoimmune necrotizing myopathy with anti-signal recognition particle antibodies. Muscle Nerve. 2017;56(6):1181\u20137. Report of juvenile cases of anti-SRP myositis.","journal-title":"Muscle Nerve"},{"issue":"Pt 8","key":"732_CR30","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/brain\/aww054","volume":"139","author":"Y Allenbach","year":"2016","unstructured":"\u2022\u2022 Allenbach Y, Keraen J, Bouvier AM, et al. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain. 2016;139(Pt 8):2131\u20135. Study of cancer risk in the different IMNM subsets.","journal-title":"Brain"},{"issue":"6","key":"732_CR31","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1212\/NXI.0000000000000290","volume":"3","author":"M Kadoya","year":"2016","unstructured":"\u2022 Kadoya M, Hida A, Hashimoto Maeda M, et al. Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy. Neurol Neuroimmunol Neuroinflamm. 2016;3(6):e290. Cancer association in Japanese anti-HMGCR myositis.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"732_CR32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/mus.24541","volume":"52","author":"V Limaye","year":"2015","unstructured":"\u2022 Limaye V, Bundell C, Hollingsworth P, et al. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase in patients with immune-mediated myositis and necrotizing myopathy. Muscle Nerve. 2015;52(2):196\u2013203. Report of the clinical features of anti-HMGCR patients from Australia.","journal-title":"Muscle Nerve"},{"issue":"10","key":"732_CR33","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","volume":"87","author":"Y Watanabe","year":"2016","unstructured":"\u2022\u2022 Watanabe Y, Uruha A, Suzuki S, et al. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry. 2016;87(10):1038\u201344. Comparison of anti-HMGCR and anti-SRP myositis in Japanese patients.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"732_CR34","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1212\/NXI.0000000000000124","volume":"2","author":"A Alshehri","year":"2015","unstructured":"\u2022 Alshehri A, Choksi R, Bucelli R, Pestronk A. Myopathy with anti-HMGCR antibodies: perimysium and myofiber pathology. Neurol Neuroimmunol Neuroinflamm. 2015;2(4):e124. Clinical and pathologic features of anti-HMGCR patients.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"732_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/acr.20662","volume":"64","author":"AL Mammen","year":"2012","unstructured":"Mammen AL, Pak K, Williams EK, Brisson D, Coresh J, Selvin E, et al. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res (Hoboken). 2012;64(2):269\u201372.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"732_CR36","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMra1515161","volume":"374","author":"AL Mammen","year":"2016","unstructured":"\u2022\u2022 Mammen AL. Statin-associated autoimmune myopathy. N Engl J Med. 2016;374(7):664\u20139. In-depth review about anti-HMGCR myositis.","journal-title":"N Engl J Med"},{"issue":"12","key":"732_CR37","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.autrev.2016.09.005","volume":"15","author":"M Alvarado-Cardenas","year":"2016","unstructured":"\u2022 Alvarado-Cardenas M, Marin-Sanchez A, Martinez MA, et al. Statin-associated autoimmune myopathy: a distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories. Autoimmun Rev. 2016;15(12):1161\u20136. New IFL pattern in anti-HMGCR myositis.","journal-title":"Autoimmun Rev"},{"key":"732_CR38","doi-asserted-by":"crossref","unstructured":"Rider LG, Werth VP, Huber AM, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken) 2011;63 Suppl 11:S118\u201357.","DOI":"10.1002\/acr.20532"},{"key":"732_CR39","doi-asserted-by":"crossref","unstructured":"Compston A. Aids to the investigation of peripheral nerve injuries. Medical Research Council: nerve injuries research committee. His Majesty\u2019s stationery office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with aids to the examination of the peripheral nervous system. By Michael O'Brien for the Guarantors of Brain. Saunders Elsevier: 2010; pp. [8] 64 and 94 figures. Brain 2010;133(10):2838\u201344.","DOI":"10.1093\/brain\/awq270"},{"issue":"4","key":"732_CR40","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","volume":"76","author":"I Pinal-Fernandez","year":"2017","unstructured":"\u2022\u2022 Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, et al. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity. Ann Rheum Dis. 2017;76(4):681\u20137. Comprehensive MRI study in patients with immune-mediated necrotizing myositis compared to other myositis subtypes.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"732_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/mus.24307","volume":"51","author":"J Vlekkert Van De","year":"2015","unstructured":"Van De Vlekkert J, Maas M, Hoogendijk JE, De Visser M, Van Schaik IN. Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy. Muscle Nerve. 2015;51(2):253\u20138.","journal-title":"Muscle Nerve"},{"issue":"6","key":"732_CR42","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/keu422","volume":"54","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Liu L, Wang L, Xiao J, Wang Z, Lv H, et al. Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle. Rheumatology (Oxford). 2015;54(6):1017\u201324.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"732_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/mus.24642","volume":"52","author":"T Chung","year":"2015","unstructured":"\u2022 Chung T, Christopher-Stine L, Paik JJ, Corse A, Mammen AL. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve. 2015;52(2):189\u201395. Pathologic features of anti-HMGCR patients.","journal-title":"Muscle Nerve"},{"issue":"6","key":"732_CR44","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","volume":"123","author":"A Selva-O'Callaghan","year":"2010","unstructured":"Selva-O'Callaghan A, Grau JM, Gamez-Cenzano C, et al. Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis. Am J Med. 2010;123(6):558\u201362.","journal-title":"Am J Med"},{"issue":"9","key":"732_CR45","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/acr.20219","volume":"62","author":"R Valiyil","year":"2010","unstructured":"Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series. Arthritis Care Res (Hoboken). 2010;62(9):1328\u201334.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"17","key":"732_CR46","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1056\/NEJMc1506163","volume":"373","author":"AL Mammen","year":"2015","unstructured":"\u2022\u2022 Mammen AL, Tiniakou E. Intravenous immune globulin for statin-triggered autoimmune myopathy. N Engl J Med. 2015;373(17):1680\u20132. Case series suggesting that IVIG in monotherapy is effective in anti-HMGCR myopathy.","journal-title":"N Engl J Med"},{"issue":"8","key":"732_CR47","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/acr.21671","volume":"64","author":"AL Mammen","year":"2012","unstructured":"Mammen AL, Gaudet D, Brisson D, Christopher-Stine L, Lloyd TE, Leffell MS, et al. Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Care Res (Hoboken). 2012;64(8):1233\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"18","key":"732_CR48","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1212\/WNL.0000000000003160","volume":"87","author":"Y Ohnuki","year":"2016","unstructured":"\u2022 Ohnuki Y, Suzuki S, Shiina T, et al. HLA-DRB1 alleles in immune-mediated necrotizing myopathy. Neurology. 2016;87(18):1954\u20135. HLA in anti-SRP and anti-HMGCR myositis.","journal-title":"Neurology"},{"issue":"4","key":"732_CR49","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000416","volume":"94","author":"Y Watanabe","year":"2015","unstructured":"Watanabe Y, Suzuki S, Nishimura H, Murata KY, Kurashige T, Ikawa M, et al. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan. Medicine (Baltimore). 2015;94(4):e416.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"732_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1615\/IntJMedMushr.v14.i4.30","volume":"14","author":"YC Lo","year":"2012","unstructured":"Lo YC, Lin SY, Ulziijargal E, Chen SY, Chien RC, Tzou YJ, et al. Comparative study of contents of several bioactive components in fruiting bodies and mycelia of culinary-medicinal mushrooms. Int J Med Mushrooms. 2012;14(4):357\u201363.","journal-title":"Int J Med Mushrooms"},{"issue":"6","key":"732_CR51","first-page":"313","volume":"34","author":"M Klimek","year":"2009","unstructured":"Klimek M, Wang S, Ogunkanmi A. Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia. P T. 2009;34(6):313\u201327.","journal-title":"P T"},{"issue":"21","key":"732_CR52","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.1021\/jf071629p","volume":"55","author":"KC Jeng","year":"2007","unstructured":"Jeng KC, Chen CS, Fang YP, Hou RC, Chen YS. Effect of microbial fermentation on content of statin, GABA, and polyphenols in pu-erh tea. J Agric Food Chem. 2007;55(21):8787\u201392.","journal-title":"J Agric Food Chem"},{"issue":"3","key":"732_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5551\/jat.12.121","volume":"12","author":"S Morikawa","year":"2005","unstructured":"Morikawa S, Murakami T, Yamazaki H, Izumi A, Saito Y, Hamakubo T, et al. Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins. J Atheroscler Thromb. 2005;12(3):121\u201331.","journal-title":"J Atheroscler Thromb"},{"key":"732_CR54","doi-asserted-by":"crossref","unstructured":"Pinal-Fernandez I, Ferrer-Fabregas B, Trallero-Araguas E, et al. Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis. Rheumatology (Oxford) 2017.","DOI":"10.1093\/rheumatology\/kex413"},{"issue":"2","key":"732_CR55","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/art.33379","volume":"64","author":"E Trallero-Araguas","year":"2012","unstructured":"Trallero-Araguas E, Rodrigo-Pendas JA, Selva-O'Callaghan A, et al. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum. 2012;64(2):523\u201332.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"732_CR56","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/art.1780341108","volume":"34","author":"RL Leff","year":"1991","unstructured":"Leff RL, Burgess SH, Miller FW, Love LA, Targoff IN, Dalakas MC, et al. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum. 1991;34(11):1391\u20136.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"732_CR57","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/ana.24902","volume":"81","author":"L Arouche-Delaperche","year":"2017","unstructured":"\u2022\u2022 Arouche-Delaperche L, Allenbach Y, Amelin D, et al. Pathogenic role of anti-signal recognition protein and anti-3-hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Ann Neurol. 2017;81(4):538\u201348. Manuscript suggesting that in vitro, anti-SRP, and anti-HMGCCR autoantibodies are pathogenic.","journal-title":"Ann Neurol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-018-0732-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0732-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0732-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T09:32:30Z","timestamp":1719912750000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-018-0732-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,26]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1007\/s11926-018-0732-6","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,26]]},"assertion":[{"value":"26 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"21"}}